Torii Pharmaceutical Co., Ltd.
TRXPF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $191,431,274,975,118 | $199,363,368,558,694 | $209,139,369,524,160 | $190,952,423,011,551 |
| - Cash | $4,838,000 | $3,767,000 | $3,319,000 | $4,995,000 |
| + Debt | $3,636 | $0 | $429,000 | $599,000 |
| Enterprise Value | $191,431,270,140,754 | $199,363,364,791,694 | $209,139,366,634,160 | $190,952,418,615,551 |
| Revenue | $115,854 | $14,683,000 | $17,093,000 | $15,024,000 |
| % Growth | -99.2% | -14.1% | 13.8% | – |
| Gross Profit | $49,551 | $6,624,000 | $5,017,000 | $6,792,000 |
| % Margin | 42.8% | 45.1% | 29.4% | 45.2% |
| EBITDA | $11,845 | $1,806,000 | $2,240,000 | $1,790,000 |
| % Margin | 10.2% | 12.3% | 13.1% | 11.9% |
| Net Income | $8,306 | $1,391,000 | $1,517,000 | $1,304,000 |
| % Margin | 7.2% | 9.5% | 8.9% | 8.7% |
| EPS Diluted | 0.3 | 49.48 | 53.97 | 46.39 |
| % Growth | -99.4% | -8.3% | 16.3% | – |
| Operating Cash Flow | – | $0 | $0 | $0 |
| Capital Expenditures | – | $0 | $0 | $0 |
| Free Cash Flow | – | $0 | $0 | $0 |